The tweet was deleted by the author.
But we saved everything 🙂.
Generali reported continued solid growth across business segments over the last nine months. Shares are little changed on the day, trading near €44.85.
Generali stated it continued to deliver solid growth nine months into the year. The company indicated that all of its business segments had a positive impact on results. Management described this as a reflection of successful execution of the current strategic plan and ongoing dedication to creating value for stakeholders.
View post on X Loading...
Generali stock opened the session with a gap up from €44.81 to €45 before giving back part of that early move. The price remains above its MA-20, MA-50, and MA-200, which continues to support a bullish daily structure. RSI is at 63.3, approaching overbought territory and indicating the recent advance may be getting stretched. The nearest resistance is at the weekly high of €45.18.
To gauge whether the revenue developments are gaining traction in the price, traders should watch for a close above €45.18 as confirmation. The session began with shares gapping up from €44.81 to €45, but that early rise has partially retraced. While the past week has seen a contained move within a narrow range, upside probability for the coming trading week is more than 80%, with downside probability less than 20%, and the expected trading range is €43.86 to €45.83. Even so, a rejection would be shown by a drop below €43.42. On the weekly chart the longer-term picture stays firmly constructive.
Previously it was reported that governance disputes within Delfin one of Generali's major shareholders, could have implications for oversight and strategy at the insurer. With Generali maintaining constructive technical momentum and broad-based operating strength, traders should monitor the €45.18 resistance as a key inflection point for potential continuation or reversal in the sessions ahead.